Literature DB >> 9831653

Ephrin-A1 is expressed at sites of vascular development in the mouse.

J L McBride1, J C Ruiz.   

Abstract

B61 (ephrin-A1), a ligand for eph receptor-protein tyrosine kinases, possesses angiogenic and endothelial cell chemoattractant activity. We report the expression profile of ephrin-A1 during mouse embryogenesis (7.25 to 10.5 days post-coitum (dpc)). Ephrin-A1 expression was first detected in the caudal end of the primitive streak and the developing allantois. At mid head fold stage, ephrin-A1 transcripts were observed in the anterior pharyngeal endoderm that underlies the site of the future heart. In 8.0 to 8.5 dpc embryos, ephrin-A1 was expressed in presumptive endocardial cells, the dorsal aorta, and the primary head veins. In 9.5 to 10.5 dpc embryos, ephrin-A1 RNA was detected in intersomitic vessels and the limb bud vasculature. Each site of ephrin-A1 expression corresponded to regions of vasculogenesis and/or angiogenesis. Copyright 1998 Elsevier Science Ireland Ltd. All Rights Reserved

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831653     DOI: 10.1016/s0925-4773(98)00142-7

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  14 in total

Review 1.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

Review 2.  Cell-cell signaling via Eph receptors and ephrins.

Authors:  Juha-Pekka Himanen; Nayanendu Saha; Dimitar B Nikolov
Journal:  Curr Opin Cell Biol       Date:  2007-10-24       Impact factor: 8.382

Review 3.  Ephs and ephrins in cancer: ephrin-A1 signalling.

Authors:  Amanda Beauchamp; Waldemar Debinski
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

4.  EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown.

Authors:  Tomonari Ojima; Hitoshi Takagi; Kiyoshi Suzuma; Hideyasu Oh; Izumi Suzuma; Hirokazu Ohashi; Daisuke Watanabe; Eri Suganami; Tomoaki Murakami; Masafumi Kurimoto; Yoshihito Honda; Nagahisa Yoshimura
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

5.  Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis.

Authors:  Birgit Mosch; Bettina Reissenweber; Christin Neuber; Jens Pietzsch
Journal:  J Oncol       Date:  2010-03-10       Impact factor: 4.375

6.  Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.

Authors:  J Wykosky; E Palma; D M Gibo; S Ringler; C P Turner; W Debinski
Journal:  Oncogene       Date:  2008-09-15       Impact factor: 9.867

7.  Molecular mechanisms of tumor angiogenesis.

Authors:  Safiyyah Ziyad; M Luisa Iruela-Arispe
Journal:  Genes Cancer       Date:  2011-12

Review 8.  Anti-angiogenic alternatives to VEGF blockade.

Authors:  Kabir A Khan; Roy Bicknell
Journal:  Clin Exp Metastasis       Date:  2015-11-30       Impact factor: 5.150

9.  Gradients of Eph-A6 expression in primate retina suggest roles in both vascular and axon guidance.

Authors:  Peter Kozulin; Riccardo Natoli; Michele C Madigan; Keely M Bumsted O'Brien; Jan M Provis
Journal:  Mol Vis       Date:  2009-12-09       Impact factor: 2.367

Review 10.  Eph receptors in breast cancer: roles in tumor promotion and tumor suppression.

Authors:  David Vaught; Dana M Brantley-Sieders; Jin Chen
Journal:  Breast Cancer Res       Date:  2008-12-22       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.